799 related articles for article (PubMed ID: 17315498)
1. [Cutaneous mastocytosis].
Flageul B
Rev Prat; 2006 Oct; 56(16):1745-51. PubMed ID: 17315498
[TBL] [Abstract][Full Text] [Related]
2. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous mastocytosis in children: a clinical analysis of 71 cases.
Kiszewski AE; Durán-Mckinster C; Orozco-Covarrubias L; Gutiérrez-Castrellón P; Ruiz-Maldonado R
J Eur Acad Dermatol Venereol; 2004 May; 18(3):285-90. PubMed ID: 15096137
[TBL] [Abstract][Full Text] [Related]
4. Pediatric cutaneous mastocytosis: a review of 180 patients.
Ben-Amitai D; Metzker A; Cohen HA
Isr Med Assoc J; 2005 May; 7(5):320-2. PubMed ID: 15909466
[TBL] [Abstract][Full Text] [Related]
5. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.
Longley BJ; Tyrrell L; Lu SZ; Ma YS; Langley K; Ding TG; Duffy T; Jacobs P; Tang LH; Modlin I
Nat Genet; 1996 Mar; 12(3):312-4. PubMed ID: 8589724
[TBL] [Abstract][Full Text] [Related]
6. C-kit Asp-816-Val mutation analysis in patients with mastocytosis.
Verzijl A; Heide R; Oranje AP; van Schaik RH
Dermatology; 2007; 214(1):15-20. PubMed ID: 17191042
[TBL] [Abstract][Full Text] [Related]
7. Serum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis.
Heide R; van Doorn K; Mulder PG; van Toorenenbergen AW; Beishuizen A; de Groot H; Tank B; Oranje AP
Clin Exp Dermatol; 2009 Jun; 34(4):462-8. PubMed ID: 19077102
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous mastocytosis in Thai children.
Singalavanija S; Limpongsanurak W
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S143-6. PubMed ID: 19253510
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous mastocytosis: demographic aspects and clinical features of 55 patients.
Akoglu G; Erkin G; Cakir B; Boztepe G; Sahin S; Karaduman A; Atakan N; Akan T; Kolemen F
J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):969-73. PubMed ID: 16922947
[TBL] [Abstract][Full Text] [Related]
10. Letter: Cutaneous mastocytosis with systemic involvement mimicking clinical and dermatoscopically multiple melanocytic nevi.
Gutiérrez-González E; Ginarte M; Toribio J
Dermatol Online J; 2011 Nov; 17(11):15. PubMed ID: 22136871
[TBL] [Abstract][Full Text] [Related]
11. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
[TBL] [Abstract][Full Text] [Related]
12. [Mastocytosis and anaesthesia].
Dewachter P; Mouton-Faivre C; Cazalaà JB; Carli P; Lortholary O; Hermine O
Ann Fr Anesth Reanim; 2009 Jan; 28(1):61-73. PubMed ID: 19097849
[TBL] [Abstract][Full Text] [Related]
13. [Diffuse cutaneous mastocytosis without permanent lesion].
Legrain V; Taïeb A; Bioulac-Sage P; Maleville J
Ann Dermatol Venereol; 1994; 121(8):561-4. PubMed ID: 7755314
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous mastocytosis in Singapore.
Tay YK; Giam YC
Singapore Med J; 1993 Oct; 34(5):425-9. PubMed ID: 8153691
[TBL] [Abstract][Full Text] [Related]
15. c-kit Mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation.
Yanagihori H; Oyama N; Nakamura K; Kaneko F
J Mol Diagn; 2005 May; 7(2):252-7. PubMed ID: 15858149
[TBL] [Abstract][Full Text] [Related]
16. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.
Bodemer C; Hermine O; Palmérini F; Yang Y; Grandpeix-Guyodo C; Leventhal PS; Hadj-Rabia S; Nasca L; Georgin-Lavialle S; Cohen-Akenine A; Launay JM; Barete S; Feger F; Arock M; Catteau B; Sans B; Stalder JF; Skowron F; Thomas L; Lorette G; Plantin P; Bordigoni P; Lortholary O; de Prost Y; Moussy A; Sobol H; Dubreuil P
J Invest Dermatol; 2010 Mar; 130(3):804-15. PubMed ID: 19865100
[TBL] [Abstract][Full Text] [Related]
17. Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.
Álvarez-Twose I; Jara-Acevedo M; Morgado JM; García-Montero A; Sánchez-Muñoz L; Teodósio C; Matito A; Mayado A; Caldas C; Mollejo M; Orfao A; Escribano L
J Allergy Clin Immunol; 2016 Jan; 137(1):168-178.e1. PubMed ID: 26100086
[TBL] [Abstract][Full Text] [Related]
18. Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT.
Foster R; Byrnes E; Meldrum C; Griffith R; Ross G; Upjohn E; Braue A; Scott R; Varigos G; Ferrao P; Ashman LK
Br J Dermatol; 2008 Nov; 159(5):1160-9. PubMed ID: 18795925
[TBL] [Abstract][Full Text] [Related]
19. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis.
Longley BJ; Morganroth GS; Tyrrell L; Ding TG; Anderson DM; Williams DE; Halaban R
N Engl J Med; 1993 May; 328(18):1302-7. PubMed ID: 7682288
[TBL] [Abstract][Full Text] [Related]
20. Biology, classification and treatment of human mastocytosis.
Valent P
Wien Klin Wochenschr; 1996; 108(13):385-97. PubMed ID: 8766423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
